AVE avecho biotechnology limited

poh: an alternative review of 2012, page-21

  1. 1,539 Posts.
    hottod,

    You are an exemplary ambassador for this Co.

    You should have a position within its ranks.

    Unfortunately POH has the unusual strategy of only giving positions to "Major Shareholders" and elevating white coated scientists to positions unfortunately.

    Do forgive me, but your incisive and expert researching on this Co is best left until they show your enthusiasm and promote from the coalface- hold back until they deliver which IMO is their responsibility.

    But then again - Right people in Wrong positions. It leaves this 14c Spec open to being outflanked by more dynamic Co's -My real dilemma at this time frame of the Co's development?



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $14.28M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $24.10K 5.355M

Buyers (Bids)

No. Vol. Price($)
9 10266426 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 17562909 21
View Market Depth
Last trade - 15.05pm 11/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.